Tripos, Semantic Web, IBM, Scripps, Applied InSilico, Ariadne Genomics, KeyMolnet, Rosetta Resolver, NHLBI | GenomeWeb

Pfizer Opts to End Tripos Collaboration; Informatics Business Not Affected

Tripos said last week that Pfizer will not renew a four-year file-enrichment collaboration that began in 2001.

Tripos received around $90 million over the project, in which it designed, synthesized, and purified a library of drug-like compounds for the pharmaceutical firm. The collaboration will end next month.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.